On March 15, after review by the State Food and Drug Administration, two new coronavirus antigen detection reagent products were approved. As of March 16, the NmPA has approved 12 new coronavirus antigen detection reagent products.
Source| State Drug Administration
The new coronavirus antigen detection reagent is applicable to the population specified in the "Application Plan for the Detection of New Coronavirus Antigens (Trial)" (Joint Prevention and Control Mechanism Comprehensive Issue [2022] No. 21).
The drug supervision and management department will strengthen the post-market supervision of relevant products to protect the safety of patients' equipment.
Attached: The New Coronavirus Antigen Detection Reagent approved by the State Food and Drug Administration
END
The 2022 National Hospital Operation Conference is coming!
From "large-scale construction" to "fine operation", how to establish a modern hospital management system? How to achieve refined, high-quality and leapfrog development of medical institutions through benign operation? How to build a market-recognized brand ?.... On May 28-29, the 2022 National Hospital Operation Conference sponsored by the 2022 Shanghai Medical Fair Expert Committee, the Institute of Social Medical Institutions of Shanghai Jiaotong University, and the medical media will be held in Shanghai.